Eiger BioPharmaceuticals, Inc. Gains 27.98%

Fri, Jun 30, 2023 at 07:58 PM

Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ) rocketted at $0.7, representing a gain of 28%. The stock appeared on our News Catalysts scanner on Thu, Jun 29, 2023 at 12:04 PM in the 'MISCELLANEOUS' category. From Fri, Jun 16, 2023, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Thu, Feb 09, 2023 at $2.98 with a volume of 9M+.

About Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ)

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.

Top 10 Gainers:

Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
VBI Vaccines Inc. (VBIV:NASDAQ), 75%
Renalytix AI plc (RNLX:NASDAQ), 43.84%
CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
PainReform Ltd. (PRFX:NASDAQ), 27.06%
Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%